Biomarker-Driven Lung Cancer Care: Application of New Standards and the Latest Research

Download All
Deepen your understanding of the role of biomarkers in lung cancer treatment and learn how to apply recent biomarker data from key clinical trials in a webcast from a live symposium, with associated downloadable slides and an expert commentary.
Todd M. Bauer, MD
Narjust Duma, MD
Karen L. Reckamp, MD, MS

Downloadable Slidesets

Download these slides from a live webinar for the most recent data on the best methods for molecular testing in NSCLC, including information on different testing methodologies, platforms, and assays as well as considerations for clinical practices and socioeconomic disparities.

Narjust Duma, MD Released: June 5, 2022

Download these slides from a live webinar for a review of recent data on treatment selection for patients with EGFR, KRAS, or HER2-positive NSCLC.

Karen L. Reckamp, MD, MS Released: June 5, 2022

Download these slides from a live webinar for the most recent data on optimal treatment approaches for patients with NSCLC that are positive for less common driver mutations, including MET, RET, ALK, ROS, and NTRK.

Todd M. Bauer, MD Released: June 5, 2022

On-Demand Webcast

In this on-demand webcast from a live symposium, oncology experts Todd M. Bauer; MD, Narjust Duma, MD; and Karen L. Reckamp, MD, MS discuss current and emerging data on biomarker testing and targeted therapy for the treatment of patients with NSCLC.

Todd M. Bauer, MD Narjust Duma, MD Karen L. Reckamp, MD, MS Physicians: maximum of 1.75 AMA PRA Category 1 Credits Released: June 7, 2022 Expired: June 6, 2023
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
Amgen
Lilly
Novartis Pharmaceuticals Corporation
Turning Point Therapeutics, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings